Bio-Rad Laboratories Net Worth 2010-2022 | BIO.B

Interactive chart of historical net worth (market cap) for Bio-Rad Laboratories (BIO.B) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Bio-Rad Laboratories net worth as of March 30, 2023 is $13.74B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.735B $2.802B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.445B 8.86
GSK (GSK) United Kingdom $75.664B 9.49
QIAGEN (QGEN) Netherlands $10.416B 19.30
Ginkgo Bioworks Holdings (DNA) United States $2.487B 0.00
Arcus Biosciences (RCUS) United States $1.286B 0.00
Biohaven (BHVN) United States $0.930B 0.00
Emergent Biosolutions (EBS) United States $0.446B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.149B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00
Gelesis Holdings (GLS) United States $0.014B 0.00